Skip to main content
Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · IEX Real-Time Price · USD
3.240
-0.090 (-2.70%)
Jul 2, 2024, 4:30 PM EDT - Market closed

Repare Therapeutics Revenue

Repare Therapeutics had revenue of $97.86M in the twelve months ending March 31, 2024, down -28.62% year-over-year. Revenue in the quarter ending March 31, 2024 was $52.40M with 822.93% year-over-year growth. In the year 2023, Repare Therapeutics had annual revenue of $51.13M, a decrease of -61.21%.

Revenue (ttm)
$97.86M
Revenue Growth
-28.62%
P/S Ratio
1.41
Revenue / Employee
$546,698
Employees
179
Market Cap
137.52M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202351.13M-80.70M-61.21%
Dec 31, 2022131.83M124.23M1,634.61%
Dec 31, 20217.60M7.47M5,529.63%
Dec 31, 2020135.00K--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
InfuSystem Holdings 127.41M
Stereotaxis 27.10M
Zomedica 25.97M
MediWound 19.85M
ProQR Therapeutics 14.66M
Revenue Rankings

RPTX News

More News